
-
Apple eases App Store rules under court pressure
-
Polls open in Australian vote swayed by inflation, Trump
-
Russell clocks second fastest 100m hurdles in history at Miami meeting
-
Germany move against far-right AfD sets off US quarrel
-
Billionaire-owned Paris FC win promotion and prepare to take on PSG
-
Teenager Antonelli grabs pole for Miami sprint race
-
Man City climb to third as De Bruyne sinks Wolves
-
Mercedes' Wolff backs Hamilton to come good with Ferrari
-
'Devastated' Prince Harry says no UK return but seeks reconciliation
-
Elway agent death likely accidental: report
-
Turkish Cypriots protest new rule allowing hijab in school
-
Germany's AfD dealt blow with right-wing extremist label
-
Trump NASA budget prioritizes Moon, Mars missions over research
-
Hard-right romps through UK polls slapping aside main parties
-
Rangers hire two-time NHL champion Sullivan as coach
-
Haaland on bench for Man City as striker returns ahead of schedule
-
US designates two Haitian gangs as terror groups
-
Lower profits at US oil giants amid fall in crude prices
-
NBA icon Popovich stepping down as Spurs coach after 29 seasons
-
'Devastated' Prince Harry says no return to UK but seeks royal reconciliation
-
Grande scratched from Kentucky Derby
-
Carney vows to transform Canada economy to withstand Trump
-
Prince Harry says he would 'love' to reconcile with family
-
Major offshore quake causes tsunami scare in Chile, Argentina
-
GM cuts shift at Canada plant over 'evolving trade environment'
-
F1 extends deal to keep Miami GP until 2041
-
Popovich mixed toughness and spirit to make NBA history
-
US asks judge to break up Google's ad tech business
-
Trump eyes huge 'woke' cuts in budget blueprint
-
Ruud downs Cerundolo to book spot in Madrid Open final
-
Gregg Popovich stepping down as San Antonio Spurs coach after 29 seasons: team
-
Guardiola to take break from football when he leaves Man City
-
Vine escapes to Tour of Romandie 3rd stage win as Baudin keeps lead
-
Olympic 100m medalist Kerley arrested, out of Miami Grand Slam meet
-
Chile, Argentina order evacuations over post-quake tsunami threat
-
Arteta 'pain' as Arsenal fall short in Premier League title race
-
Hard-right romps across UK local elections slapping down main parties
-
US ends duty-free shipping loophole for low-cost goods from China
-
Renewables sceptic Peter Dutton aims for Australian PM's job
-
Australians vote in election swayed by inflation, Trump
-
Syria slams Israeli Damascus strike as 'dangerous escalation'
-
Grand Theft Auto VI release postponed to May 2026
-
Lawyers probe 'dire' conditions for Meta content moderators in Ghana
-
Maresca confident Chelsea can close gap to Liverpool
-
Watchdog accuses papal contenders of ignoring sex abuse
-
Berlin culture official quits after funding cut backlash
-
US hiring better than expected despite Trump uncertainty
-
EU fine: TikTok's latest setback
-
Stocks gain on US jobs data, tariff talks hopes
-
Barca's Ter Stegen to return from long lay-off for Valladolid trip

Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
M.Fischer--AMWN